Real-Time fMRI Neurofeedback in Patients With Tobacco Use Disorder During Smoking Cessation: Functional Differences and Implications of the First Training Session in Regard to Future Abstinence or Relapse.
craving
neurofeedback
real-time fMRI
therapy success
tobacco use disorder
Journal
Frontiers in human neuroscience
ISSN: 1662-5161
Titre abrégé: Front Hum Neurosci
Pays: Switzerland
ID NLM: 101477954
Informations de publication
Date de publication:
2019
2019
Historique:
received:
20
11
2018
accepted:
08
02
2019
entrez:
20
3
2019
pubmed:
20
3
2019
medline:
20
3
2019
Statut:
epublish
Résumé
One of the most prominent symptoms in addiction disorders is the strong desire to consume a particular substance or to show a certain behavior (craving). The strong association between craving and the probability of relapse emphasizes the importance of craving in the therapeutic process. Former studies have demonstrated that neuromodulation using real-time fMRI (rtfMRI) neurofeedback (NF) can be used as a treatment modality in patients with tobacco use disorder. The aim of the present project was to determine whether it is possible to predict the outcome of NF training plus group psychotherapy at the beginning of the treatment. For that purpose, neuronal responses during the first rtfMRI NF session of patients who remained abstinent for at least 3 months were compared to those of patients with relapse. All patients were included in a certified smoke-free course and took part in three NF sessions. During the rtfMRI NF sessions tobacco-associated and neutral pictures were presented. Subjects were instructed to reduce their neuronal responses during the presentation of smoking cues in an individualized region of interest for craving [anterior cingulate cortex (ACC), insula or dorsolateral prefrontal cortex]. Patients were stratified to different groups [abstinence (
Identifiants
pubmed: 30886575
doi: 10.3389/fnhum.2019.00065
pmc: PMC6409331
doi:
Types de publication
Journal Article
Langues
eng
Pagination
65Références
J Consult Clin Psychol. 2000 Apr;68(2):233-40
pubmed: 10780123
Trends Cogn Sci. 2000 Jun;4(6):215-222
pubmed: 10827444
Am J Psychiatry. 2002 Oct;159(10):1642-52
pubmed: 12359667
Neuroimage. 2003 Mar;18(3):760-8
pubmed: 12667853
Behav Neurosci. 2003 Apr;117(2):369-80
pubmed: 12708533
Neuroimage. 2003 Jul;19(3):577-86
pubmed: 12880789
Lancet. 2003 Sep 13;362(9387):847-52
pubmed: 13678970
J Pers Soc Psychol. 1992 Sep;63(3):452-9
pubmed: 1403624
Lung Cancer. 2004 Aug;45 Suppl 2:S3-9
pubmed: 15552776
Nicotine Tob Res. 2004 Dec;6(6):899-912
pubmed: 15801566
Neuropsychopharmacology. 2005 Oct;30(10):1940-7
pubmed: 15920499
Nicotine Tob Res. 2005 Aug;7(4):637-45
pubmed: 16085533
Psychopharmacology (Berl). 2006 Mar;184(3-4):577-88
pubmed: 16133128
Clin Psychol Rev. 2006 Mar;26(2):196-215
pubmed: 16352382
Biol Psychiatry. 2007 Sep 15;62(6):642-51
pubmed: 17217932
Neuroimage. 2007 Apr 15;35(3):1238-46
pubmed: 17336094
Int J Psychophysiol. 2007 Nov;66(2):109-15
pubmed: 17544533
Br J Addict. 1991 Nov;86(11):1467-76
pubmed: 1777741
Trends Cogn Sci. 2007 Nov;11(11):473-81
pubmed: 17988931
Lancet. 2008 Jun 14;371(9629):2027-38
pubmed: 18555914
Hum Brain Mapp. 2009 May;30(5):1605-14
pubmed: 18661503
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Neuroimage. 2010 Jan 1;49(1):1066-72
pubmed: 19646532
Clin Ther. 2009 Sep;31(9):1957-65
pubmed: 19843485
Biol Psychiatry. 2010 Apr 15;67(8):722-9
pubmed: 20172508
Brain Struct Funct. 2010 Jun;214(5-6):435-50
pubmed: 20512364
Biol Psychiatry. 2010 Sep 1;68(5):425-32
pubmed: 20570245
Addiction. 2010 Aug;105(8):1362-80
pubmed: 20653619
Addict Biol. 2010 Oct;15(4):491-503
pubmed: 20840335
Neuroimage. 2011 Feb 1;54(3):2503-13
pubmed: 20946960
Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv
pubmed: 21040645
Neuropsychobiology. 2011;63(1):43-51
pubmed: 21063132
Hum Brain Mapp. 2011 Jan;32(1):22-31
pubmed: 21157877
Neurorehabil Neural Repair. 2011 Mar-Apr;25(3):259-67
pubmed: 21357528
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):121-5
pubmed: 21677237
Addict Biol. 2011 Oct;16(4):654-66
pubmed: 21790899
Psychol Rev. 1990 Apr;97(2):147-68
pubmed: 2186423
PLoS One. 2011;6(9):e24522
pubmed: 21931738
Hum Brain Mapp. 2013 Jan;34(1):200-12
pubmed: 22021045
Neuroimage. 2012 Mar;60(1):252-62
pubmed: 22206965
Addict Biol. 2013 Jul;18(4):739-48
pubmed: 22458676
Am J Addict. 2012 May-Jun;21(3):210-20
pubmed: 22494223
Psychol Addict Behav. 2013 Jun;27(2):501-9
pubmed: 22564200
J Atten Disord. 2013 Jul;17(5):410-9
pubmed: 22617866
PLoS One. 2012;7(6):e38115
pubmed: 22675513
Psychiatry Res. 2013 Jan 30;211(1):85-7
pubmed: 23146252
Nicotine Tob Res. 2013 Jul;15(7):1167-82
pubmed: 23291636
Front Psychiatry. 2013 Mar 22;4:17
pubmed: 23525496
N Engl J Med. 2013 May 2;368(18):1753
pubmed: 23635064
Psychiatry Res. 2013 Jul 30;213(1):79-81
pubmed: 23683344
Nicotine Tob Res. 2013 Dec;15(12):2120-4
pubmed: 23935182
Health Educ Res. 2013 Oct;28(5):869-78
pubmed: 23962493
Cochrane Database Syst Rev. 2013 Aug 20;(8):CD003999
pubmed: 23963584
Tijdschr Psychiatr. 2013;55(11):841-52
pubmed: 24242143
Ann N Y Acad Sci. 2014 May;1316:53-70
pubmed: 24690001
Addiction. 2015 Feb;110(2):195-203
pubmed: 25073979
Neuroimage Clin. 2014 Jul 10;5:245-55
pubmed: 25161891
Int J Neuropsychopharmacol. 2015 Feb 25;18(6):null
pubmed: 25716778
J Cogn Neurosci. 2015 Aug;27(8):1552-72
pubmed: 25761006
Neuropsychopharmacology. 2015 Oct;40(11):2648-56
pubmed: 25895453
Addict Biol. 2016 Jul;21(4):982-92
pubmed: 26096546
Neuroscience. 2015 Aug 20;301:529-41
pubmed: 26116518
PLoS One. 2015 Jul 23;10(7):e0133034
pubmed: 26204262
Ann N Y Acad Sci. 2015 Sep;1349:64-82
pubmed: 26348486
J Psychiatry Neurosci. 2016 Jan;41(1):48-55
pubmed: 26505139
Cereb Cortex. 2017 Feb 1;27(2):1193-1202
pubmed: 26679192
Neuroimage. 2017 May 1;151:24-32
pubmed: 26975550
Drug Alcohol Depend. 2016 Oct 01;167:75-81
pubmed: 27522872
Magn Reson Imaging. 2017 Jan;35:117-124
pubmed: 27569365
Neuroimage. 2017 May 1;151:45-54
pubmed: 27864080
Nat Rev Neurosci. 2017 Feb;18(2):86-100
pubmed: 28003656
PLoS One. 2017 Jan 26;12(1):e0170795
pubmed: 28125735
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:142-147
pubmed: 28185963
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):143-154
pubmed: 28322982
Drug Alcohol Depend. 2017 Oct 1;179:8-12
pubmed: 28735078
Addict Biol. 2018 Sep;23(5):1189-1199
pubmed: 28877410
Behav Res Methods. 2019 Feb;51(1):195-203
pubmed: 30734206
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124